| Literature DB >> 34172011 |
Cui-Lin Shi1,2, Jian-Ping Zhang2, Ping Xu2, Jin Li2, Jie Shen2, Mei-Ying Wu2, Zhi-Jian Ye2, Xin Yu2, Hua-Feng Song2, Hui Chen2, Jun-Chi Xu3, Yu Pang4, Jian-An Huang5.
Abstract
BACKGROUND: Health care workers (HCWs) are at risk for occupationally acquired Mycobacterium tuberculosis infection and tuberculosis (TB) disease due to repeated exposure to workplace tubercle bacilli. To determine whether continual mycobacterial stimulation correlates with increased expression of inhibitory T cell receptors, here we compared PD-1 receptor expression on surfaces of circulating T cells between naïve (uninfected) HCWs and HCWs with latent TB infection (LTBI). RESULT: Data collected from 133 medical workers who met study selection criteria were included in the final analysis. QuantiFERON-TB Gold In-Tube (QFT-GIT) testing yielded positive results for 32 HCWs, for an overall LTBI rate of 24.1%. Multivariate analysis identified HCW length of service > 15 years as an independent risk factor for a positive QFT-GIT result. In addition, comparisons of blood T cell subgroup profiles between QFT- and QFT+ groups indicated QFT+ subjects possessed greater proportions of mature (TM), transitional memory (TTM) and effector memory (TEM) CD4+ T cell subgroups and lower proportions of naïve T cells (TN). Moreover, the QFT+ group percentage of CD8+ T cells with detectable surface PD-1 was significantly higher than the corresponding percentage for the QFT- group. Meanwhile, no statistical intergroup difference was observed in percentages of CD4+ T cells with detectible surface PD-1.Entities:
Keywords: Health care worker; Immunodepletion; Latent tuberculosis infection; PD-1; T cell
Mesh:
Substances:
Year: 2021 PMID: 34172011 PMCID: PMC8234730 DOI: 10.1186/s12865-021-00433-9
Source DB: PubMed Journal: BMC Immunol ISSN: 1471-2172 Impact factor: 3.615
Fig. 1Study flow diagram. HCWs: health care workers; QFT: QuantiFERON-Gold In-Tube assay
Baseline Characteristics of medical worker
| Characteristics | Total | QFT +( | QFT -( | Statistical value | |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 28 (21.1) | 5 (15.6) | 23 (22.8) | 0.747 | 0.387 |
| Female | 105 (78.9) | 27 (84.4) | 78 (77.2) | ||
| Age | 35.1 ± 8.4 | 38.0 ± 8.0 | 34.2 ± 5.2 | −1.763 | 0.078 |
| Working time (year) | 12.5 ± 10.0 | 16.5 ± 8.5 | 11.2 ± 6.2 | −2.833 | 0.005 |
| < =2 | 15 (11.3) | 1 (3.1) | 14 (13.9) | 13.067 | < 0.001 |
| (3–5) | 20 (15.0) | 0 | 20 (19.8) | ||
| (6–15) | 61 (45.9) | 16 (50) | 45 (44.6) | ||
| (16–25) | 12 (9.0) | 6 (18.8) | 6 (5.9) | ||
| > 25 | 25 (18.8) | 9 (28.1) | 16 (15.8) | ||
| Occupation | |||||
| Doctor | 34 (25.6) | 11 (34.3) | 23 (22.8) | 7.891 | 0.048 |
| Nurse | 79 (59.4) | 21 (65.7) | 58 (57.4) | ||
| Laboratory staff | 13 (9.8) | 0 | 13 (12.8) | ||
| Radiologist | 7 (5.3) | 0 | 7 (7.0) | ||
| Chronic medical illness | |||||
| Hypertension | 4 (3.0) | 2 (6.3) | 2 (2.0) | 3.058 | 0.09 |
| Type 2 diabetes | 5 (3.8) | 3 (9.4) | 2 (2.0) | 1.3 | 0.244 |
| Clinical biochemical index | |||||
| White blood cell count(WBC), 10^9/L | 6.063 ± 0.938 | 6.701 ± 1.651 | −0.993 | 0.321 | |
| Lymphocyte count(L), 10^9/L | 2.059 ± 0.451 | 2.131 ± 0.421 | −0.704 | 0.481 | |
| Alanine aminotransferase(ALT), U/L | 17.969 ± 9.469 | 21.457 ± 12.707 | −0.993 | 0.321 | |
| Plasma creatinine, μmol/L | 59.941 ± 8.941 | 63.823 ± 8.823 | −1.752 | 0.08 | |
| Cellular immunological index | |||||
| CD4+ T cell count, 10^9/L | 0.727 ± 0.246 | 0.763 ± 0.225 | 0.772 | 0.442 | |
| CD8+ T cell count, 10^9/L | 0.569 ± 0.193 | 0.558 ± 0.213 | −0.263 | 0.793 | |
| T cell count, 10^9/L | 1.391 ± 0.283 | 1.431 ± 0.315 | −0.156 | 0.876 | |
| B cell count, 10^9/L | 0.242 ± 0.097 | 0.248 ± 0.082 | −0.024 | 0.981 | |
| NK cell count, 10^9/L | 17.061 ± 5.231 | 18.14 ± 6.205 | −0.303 | 0.762 | |
Univariate and multivariate analysis of factors associated with positive or negative QFT-G result
| Variable | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| OR | 95%CI | 0R | 95%CI | |||
| Age | 1.053 | 1.005–1.103 | 0.029 | |||
| Sex | 1.592 | 0.551–4.603 | 0.390 | 0.827 | 0.172–3.973 | 0.813 |
| work time (≤15 vs > 15) | 3.168 | 1.368–7.338 | 0.007 | 0.249 | 0.090–0.686 | 0.007 |
| Hypertension | 0.303 | 0.041–2.244 | 0.242 | 0.564 | 0.062–5.097 | 0.61 |
| Plasma creatinine, μmol/L | 0.975 | 0.942–1.009 | 0.146 | 0.969 | 0.923–1.017 | 0.203 |
| CD4+T cell count, 10^9/L | 0.997 | 0.937–1.061 | 0.928 | 0.838 | 0.002–479.941 | 0.956 |
| CD8+ T cell count, 10^9/L | 1.038 | 0.981–1.099 | 0.198 | 23.342 | 0.031–17,527.830 | 0.351 |
| T cell count, 10^9/L | 0.784 | 0.286–2.153 | 0.637 | 0.810 | 0.004–157.836 | 0.937 |
| B cell count, 10^9/L | 0.597 | 0.016–21.626 | 0.778 | 0.404 | 0.001–136.131 | 0.76 |
| NK cell count, 10^9/L | 0.981 | 0.928–1.037 | 0.495 | 0.452 | 0.028–7.207 | 0.574 |
Fig. 2Gating strategy and expression profiles of memory CD4+ T cell subpopulation in latent TB-infected HCWs. A Gating strategies and representative results for the CD4+ T cell subpopulation. B Analysis of expression differences between memory CD4+ T cells of QFT+ and QFT- groups. C Analysis of expression differences between naïve CD4+ T cells in QFT+ and QFT- groups. D Analysis of expression differences between transitional memory CD4+ T cells in QFT+ and QFT- groups. E Analysis of expression differences between central memory CD4+ T cells in QFT+ and QFT- groups. FAnalysis of expression differences between effector memory CD4+ T cells in QFT+ and QFT- groups
Fig. 3Gating strategy and the expression profiles of memory CD8+ T cell subpopulation in latent TB-infected HCWs. A Gating strategies and representative results for the CD8+ T cell subpopulation. B Analysis of expression differences between memory CD8+ T cells in QFT+ and QFT- groups. CAnalysis of expression differences between naive CD8+ T cells in QFT+ and QFT- groups. D Analysis of expression differences between transitional memory CD8+ T cells in QFT+ and QFT- groups. EAnalysis of expression differences between central memory CD8+ T cells in QFT+ and QFT- groups. F Analysis of expression differences between effector memory CD8+ T cells in QFT+ and QFT- groups
Fig. 4Expression of PD-1 on T cells in latent TB-infected HCWs. A Gating strategies and representative results related to PD-1 expression on T cells. B Analysis of PD-1 expression differences between CD4+ T cells in QFT+ and QFT- groups. C Analysis of PD-1 expression differences between CD8+ T cells in QFT+ and QFT- groups